Mechanistic Investigation of Adociaquinone and Xestoquinone Derivatives in Breast Cancer Cells

Yu-Dong Zhou1, Fakhri Mahdi2, Nicholas M Nagle3

  • 1National Center for Natural Products Research, School of Pharmacy, University of Mississippi, Oxford, MS 38677-1848, USA.

Marine Drugs
|December 24, 2025
PubMed

Insights

Marine sponge compounds called xestoquinones inhibit tumor growth by disrupting cellular respiration and protein synthesis. Some derivatives act as protonophores, while others utilize redox cycling, offering potential anti-cancer therapeutic strategies.

Area of Science:

  • Marine Natural Products Chemistry
  • Cancer Biology
  • Mitochondrial Physiology

Background:

  • Xestoquinone derivatives from marine sponges show diverse bioactivities.
  • These compounds target critical cellular processes like HIF signaling and mitochondrial function.
  • Understanding their mechanisms is key for therapeutic development.

Purpose of the Study:

  • To investigate the bioactivities and mechanisms of action of xestoquinone derivatives.
  • To elucidate how these compounds inhibit HIF signaling and tumor cell proliferation.
  • To explore their effects on mitochondrial respiration and protein translation.

Main Methods:

  • Isolation and characterization of xestoquinone derivatives from marine sponges.
  • Measurement of cellular oxygen consumption and mitochondrial membrane potential.
  • Analysis of protein translation inhibition and activation of stress response pathways.

Main Results:

  • 14-hydroxymethylxestoquinone acts as a protonophore.
  • Adociaquinones stimulate oxygen consumption via ascorbate-supported redox cycling, suppressing HIF and tumor cell proliferation.
  • Xestoquinones activate stress pathways, inhibiting protein translation by phosphorylating eIF2α, eIF4E, and eEF2.
  • Sulfhydryl modification is implicated in the mechanism of action.

Conclusions:

  • Xestoquinone derivatives possess potent anti-cancer properties by interfering with mitochondrial function and protein synthesis.
  • Mechanisms involve protonophore activity, redox cycling, and modulation of stress response pathways.
  • Potential therapeutic applications against cancer warrant further investigation.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...